3pjf Citations

Structural basis of triclosan resistance.

J Struct Biol 174 173-9 (2011)
Related entries: 3pjd, 3pje

Cited: 8 times
EuropePMC logo PMID: 21094257

Abstract

Triclosan (5-chloro-2-(2,4-dichloro-phenoxy)-phenol, TCL) is a well known inhibitor against enoyl-acyl carrier protein reductase (ENR), an enzyme critical for cell-wall synthesis of bacteria. The inhibitory concentration at 50% inhibition (IC(50)) of TCL against the Escherichia coli ENR is 150nM for wild type (WT), 380, 470 and 68,500nM for Ala, Ser and Val mutants, respectively. To understand this high TCL resistance in the G93V mutant, we obtained the crystal structures of mutated ENRs complexed with TCL and NAD(+). The X-ray structural analysis along with the ab initio calculations and molecular dynamics simulations explains the serious consequence in the G93V mutant complex. The major interactions around TCL due to the aromatic(cation)-aromatic and hydrogen bonding interactions are found to be conserved both in WT and mutant complexes. Thus, the overall structural change of protein is minimal except that a flexible α-helical turn around TCL is slightly pushed away due to the presence of the bulky valine group. However, TCL shows substantial edge-to-face aromatic (π)-interactions with both the flexible R192-F203 region and the residues in the close vicinity of G93. The weakening of some edge-to-face aromatic interactions around TCL in the G93V mutant results in serious resistance to TCL. This understanding is beneficial to design new generation of antibiotics which will effectively act on the mutant ENRs.

Articles citing this publication (8)

  1. Dental composite materials containing carolacton inhibit biofilm growth of Streptococcus mutans. Apel C, Barg A, Rheinberg A, Conrads G, Wagner-Döbler I. Dent Mater 29 1188-1199 (2013)
  2. In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors. Lindert S, Tallorin L, Nguyen QG, Burkart MD, McCammon JA. J Comput Aided Mol Des 29 79-87 (2015)
  3. Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery. Lindert S, McCammon JA. Protein Sci 21 1734-1745 (2012)
  4. The impact of DNA adenine methyltransferase knockout on the development of triclosan resistance and antibiotic cross-resistance in Escherichia coli. Hughes L, Roberts W, Johnson D. Access Microbiol 3 acmi000178 (2021)
  5. How Diverse Are the Protein-Bound Conformations of Small-Molecule Drugs and Cofactors? Friedrich NO, Simsir M, Kirchmair J. Front Chem 6 68 (2018)
  6. The introduction of metagenomics into an undergraduate biochemistry laboratory course yielded a predicted reductase that decreases triclosan susceptibility in Escherichia coli. Donato JJ, Klimstra MA, Byrnes JR, White RJ, Marsh TC. DNA Cell Biol 31 968-973 (2012)
  7. Ligand- and Structure-Based Approaches of Escherichia coli FabI Inhibition by Triclosan Derivatives: From Chemical Similarity to Protein Dynamics Influence. Kronenberger T, de Oliveira Fernades P, Drumond Franco I, Poso A, Gonçalves Maltarollo V. ChemMedChem 14 1995-2004 (2019)
  8. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure-activity relationship analyses. Kronenberger T, Asse LR, Wrenger C, Trossini GH, Honorio KM, Maltarollo VG. Future Med Chem 9 135-151 (2017)